COLLAGENASE IN THE TREATMENT OF DUPUYTREN'S DISEASE

胶原酶治疗掌腱膜挛缩症

• 批准号: 7607840
• 负责人: MARIE A BADALAMENTE
• 金额: $ 0.76万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-03-23 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607840
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Contracture; Disease; Double-Blind Method; Funding; Grant; Hand deformities; Injectable; Institution; Operative Surgical Procedures; Phase; Placebos; Research; Research Personnel; Resources; Source; United States National Institutes of Health; collagenase

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A Phase II random, placebo double blind trial of injectable collagenase is being studied as a non-operative treatment for Dupuytren's disease, a fixed flexion contracture deformity of the hand. This therapy may obviate the need for surgical fasciectomy for Dupuytren's disease.

这个子项目是众多研究子项目之一